Prevalence, incidence and carrier frequency of 5q–linked spinal muscular atrophy–a literature review
IEC Verhaart, A Robertson, IJ Wilson… - Orphanet journal of rare …, 2017 - Springer
Spinal muscular atrophy linked to chromosome 5q (SMA) is a recessive, progressive,
neuromuscular disorder caused by bi-allelic mutations in the SMN1 gene, resulting in motor …
neuromuscular disorder caused by bi-allelic mutations in the SMN1 gene, resulting in motor …
New treatments in spinal muscular atrophy: positive results and new challenges
S Messina, M Sframeli - Journal of clinical medicine, 2020 - mdpi.com
Spinal muscular atrophy (SMA) is one of the most common autosomal recessive diseases
with progressive weakness of skeletal and respiratory muscles, leading to significant …
with progressive weakness of skeletal and respiratory muscles, leading to significant …
Correlation between SMA type and SMN2 copy number revisited: an analysis of 625 unrelated Spanish patients and a compilation of 2834 reported cases
M Calucho, S Bernal, L Alías, F March… - Neuromuscular …, 2018 - Elsevier
Spinal muscular atrophy (SMA) is a neuromuscular disorder caused by loss or mutations in
SMN1. According to age of onset, achieved motor abilities, and life span, SMA patients are …
SMN1. According to age of onset, achieved motor abilities, and life span, SMA patients are …
Advances in treatment of spinal muscular atrophy–new phenotypes, new challenges, new implications for care
DC Schorling, A Pechmann… - Journal of …, 2020 - content.iospress.com
Abstract Spinal Muscular Atrophy (SMA) is caused by autosomal recessive mutations in
SMN1 and results in the loss of motor neurons and progressive muscle weakness. The …
SMN1 and results in the loss of motor neurons and progressive muscle weakness. The …
Spinal muscular atrophy: in the challenge lies a solution
B Wirth - Trends in neurosciences, 2021 - cell.com
The path from gene discovery to therapy in spinal muscular atrophy (SMA) has been a
highly challenging endeavor, but also led to one of the most successful stories in …
highly challenging endeavor, but also led to one of the most successful stories in …
Clinical evidence supporting early treatment of patients with spinal muscular atrophy: current perspectives
T Dangouloff, L Servais - Therapeutics and clinical risk …, 2019 - Taylor & Francis
Recent advances in the treatment of spinal muscular atrophy (SMA) have dramatically
altered prognosis. Rather than a rapidly lethal disease, SMA type 1, the most severe form …
altered prognosis. Rather than a rapidly lethal disease, SMA type 1, the most severe form …
Twenty-five years of spinal muscular atrophy research: from phenotype to genotype to therapy, and what comes next
Twenty-five years ago, the underlying genetic cause for one of the most common and
devastating inherited diseases in humans, spinal muscular atrophy (SMA), was identified …
devastating inherited diseases in humans, spinal muscular atrophy (SMA), was identified …
One year of newborn screening for SMA–results of a German pilot project
K Vill, H Kölbel, O Schwartz, A Blaschek… - Journal of …, 2019 - content.iospress.com
Objective: Spinal muscular atrophy (SMA) is the most common neurodegenerative disease
in childhood. The study was conducted to assess the impact of early detection of SMA by …
in childhood. The study was conducted to assess the impact of early detection of SMA by …
[HTML][HTML] Copy Number Variations in the Survival Motor Neuron Genes: Implications for Spinal Muscular Atrophy and Other Neurodegenerative Diseases
MER Butchbach - Frontiers in molecular biosciences, 2016 - frontiersin.org
Proximal spinal muscular atrophy (SMA), a leading genetic cause of infant death worldwide,
is an early-onset, autosomal recessive neurodegenerative disease characterized by the loss …
is an early-onset, autosomal recessive neurodegenerative disease characterized by the loss …
[PDF][PDF] Neurocalcin delta suppression protects against spinal muscular atrophy in humans and across species by restoring impaired endocytosis
M Riessland, A Kaczmarek, S Schneider… - The American Journal of …, 2017 - cell.com
Homozygous SMN1 loss causes spinal muscular atrophy (SMA), the most common lethal
genetic childhood motor neuron disease. SMN1 encodes SMN, a ubiquitous housekeeping …
genetic childhood motor neuron disease. SMN1 encodes SMN, a ubiquitous housekeeping …